Abstract
ObjectiveThe paper projects the contribution to 2011–2015 international targets of three major pandemics by programs in 140 countries funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria, the largest external financier of tuberculosis and malaria programs and a major external funder of HIV programs in low and middle income countries.DesignEstimates, using past trends, for the period 2011–2015 of the number of persons receiving antiretroviral (ARV) treatment, tuberculosis case detection using the internationally approved DOTS strategy, and insecticide-treated nets (ITNs) to be delivered by programs in low and middle income countries supported by the Global Fund compared to international targets established by UNAIDS, Stop TB Partnership, Roll Back Malaria Partnership and the World Health Organisation.ResultsGlobal Fund-supported programs are projected to provide ARV treatment to 5.5–5.8 million people, providing 30%–31% of the 2015 international target. Investments in tuberculosis and malaria control will enable reaching in 2015 60%–63% of the international target for tuberculosis case detection and 30%–35% of the ITN distribution target in sub-Saharan Africa.ConclusionGlobal Fund investments will substantially contribute to the achievement by 2015 of international targets for HIV, TB and malaria. However, additional large scale international and domestic financing is needed if these targets are to be reached by 2015.
Highlights
In 2000, at the United Nations Millennium Summit the international community committed to achieving the Millennium Development Goals (MDGs) [1] including Goal 4 on reducing child mortality, Goal 5 on improving maternal health and Goal 6 to combat HIV/AIDS, malaria and other communicable diseases such as tuberculosis (TB) with targets for each aimed at addressing the huge burden of disease, which in 2008 led to 2 million (1.7–2.4 million) AIDS deaths [2], 1,318,108 (1,087,802–1,672,447) deaths due to TB [3], and 863,000 (708,000–1,003,000) malaria deaths [4]
Results reported by programs Past results (2005–10) of Global Fund-supported programs reported by the end of 2010 were compared with international targets
Programmatic results relate to people reached with goods and services; e.g. the number of people receiving ARVs, the number of new smear-positive TB cases detected under the DOTS strategy, and the number of insecticide-treated nets (ITNs) distributed [16]
Summary
In 2000, at the United Nations Millennium Summit the international community committed to achieving the Millennium Development Goals (MDGs) [1] including Goal 4 on reducing child mortality, Goal 5 on improving maternal health and Goal 6 to combat HIV/AIDS, malaria and other communicable diseases such as tuberculosis (TB) with targets for each aimed at addressing the huge burden of disease, which in 2008 led to 2 million (1.7–2.4 million) AIDS deaths [2], 1,318,108 (1,087,802–1,672,447) deaths due to TB [3], and 863,000 (708,000–1,003,000) malaria deaths [4]. These commitments have prompted governments, development agencies, new financing institutions such as the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), technical organizations, and the civil society to massively scale up investments and life-saving and preventive interventions for addressing these epidemics These efforts have enabled low- and middle-income countries to expand the number of people receiving antiretroviral (ARV) treatment from 300,000 in 2002 to 5.25 million by the end of 2009 [6]; increase in the number of long lasting insecticidal nets (LLINs) distributed in 35 high-burden African countries from less than 10 million in 2004 to 35–44 million per year between 2006–2008 [4]; and boost the detection rate of new smear-positive tuberculosis cases from 40% (36%– 44%) in 2000 to 61% (55%–67%) in 2008 [3]. An up to date assessment of progress in relation to service delivery targets is timely
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
